Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma [NA]
A completed clinical trial evaluating magnetic resonance spectroscopy imaging to predict response to vorinostat and temozolomide in recurren…
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection [Phase 2]
Phase 2 clinical trial evaluating the reproducibility of 18F uptake in solid tumors using PET imaging after intravenous administration of a …
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma [Phase 1]
Phase 1 clinical trial assessing aflibercept in combination with radiation therapy and temozolomide in adults with newly diagnosed or recurr…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma [Phase 1]
This update covers a Phase 1 trial of sorafenib in patients with recurrent or progressive malignant glioma, including several glioma subtype…
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma [Phase 1]
A Phase 1 study evaluating the peptide-based glioma vaccine IMA950 in patients with glioblastoma has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma [Phase 1, Phase 2]
Phase 1/2 dose-escalation study of Locally-Administered OncoGel in recurrent glioma was terminated; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: TRC105 for Recurrent Glioblastoma [Phase 2]
Phase 2 trial of TRC105 for recurrent glioblastoma was terminated; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma [Phase 3]
A Phase 3 trial evaluating radiation therapy with temozolomide for newly diagnosed glioblastoma or gliosarcoma has completed with results po…
-
CLINICAL_TRIALS trial_result · 2014-04-24Clinical Trial Update: Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse [Phase 2]
Phase 2 dose confirmation study of Cotara for glioblastoma at first relapse has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Epothilone in Recurrent Glioblastoma Patients [Phase 2]
Phase 2 trial update for epothilone in recurrent glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Dose-Intense Temozolomide in Recurrent Glioblastoma [Phase 2]
Phase 2 trial assessing a dose-intensive temozolomide regimen in patients with recurrent glioblastoma and gliosarcoma; results were posted i…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme) [Phase 2]
A Phase 2 study evaluating Tarceva (erlotinib) for safety and efficacy in patients with first relapse glioblastoma; the trial has been compl…
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy [Phase 2]
This Phase 2, NCI-sponsored trial evaluated cilengitide in children and adolescents with recurrent or progressive high-grade glioma refracto…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma [Phase 1]
Phase 1 study evaluating the safety and potential activity of bevacizumab plus cediranib in patients with metastatic or unresectable solid t…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma [Phase 2]
A Phase II study evaluating bevacizumab (Avastin) with bortezomib for recurrent malignant glioma has completed and posted results, involving…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Cilengitide Imaging Trial in Glioblastoma [Phase 1]
Phase 1 imaging trial of cilengitide in supratentorial newly diagnosed inoperable glioblastoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
An update on a clinical trial evaluating Q Cell in glioma patients, focusing on treatment response and prognosis.
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma [Phase 2]
This Phase 2 clinical trial evaluates the efficacy of protracted temozolomide in patients with progressive high-grade glioma, including glio…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Ketogenic Diet for Recurrent Glioblastoma [Phase 1]
A Phase 1 trial evaluating the ketogenic diet for recurrent glioblastoma has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas [Phase 2]
A Phase 2 trial evaluating bevacizumab plus irinotecan in recurrent gliomas (glioblastoma and astrocytoma) has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma [Phase 2]
A Phase IIb trial of AP-12009, a TGF-β2 antisense oligonucleotide, for recurrent or refractory high-grade glioma including glioblastoma and …
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme [Phase 1, Phase 2]
Clinical trial update showing completion of Phase 1 and Phase 2 studies of NPC-08 for newly diagnosed malignant glioma and recurrent gliobla…
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas [Phase 1]
This is a completed Phase I trial evaluating an oral combination of topotecan and temozolomide for malignant gliomas, including glioblastoma…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs [Phase 1]
Phase 1 trial update of PTK787/ZK 222584 in combination with temozolomide and radiation for glioblastoma patients taking enzyme-inducing ant…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme [Phase 1]
A Phase 1 trial of boron phenylalanine with or without mannitol for glioblastoma multiforme has been terminated.